Form 4/A for DXCM Dexcom
Accepted 2025-07-07 00:00:00 ET · period of report 2025-05-08 · accession 0001093557-25-000224 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| A | 2025-07-07 | 2025-05-08 | DXCM | GALA RENEE D | Dir | A - Grant | $0.00 | +1,161 | 6,881 | +20% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-05-08 | A | A | 1,161 | $0.00 | 6,881 | D | — | — | (F2) Represents unvested restricted stock units which were granted on May 8, 2025 and shall vest on the earlier of the one year anniversary of the grant date or the date of DexCom, Inc.'s 2026 Annual Meeting of Stockholders. (F1) The original Form 4, filed on May 12, 2025, is being amended by this Form 4 to correct a calculation error that misreported the number of unvested restricted stock units granted to the reporting person on May 8, 2025. This amendment correctly reports the number of unvested restricted stock units granted to the reporting person on May 8, 2025. (F3) Included in this number are 6,881 unvested restricted stock units, 5,720 of which were granted on March 6, 2025 and shall vest through March 6, 2028 and 1,161 of which were granted on May 8, 2025 and shall vest on the earlier of the one year anniversary of the grant date or the date of DexCom, Inc.'s 2026 Annual Meeting of Stockholders. |